Health Blueprint

Back to Longevity News

News summary

Citius Oncology Reports Continued Institutional Demand and 120% Growth in Shipments of LYMPHIR® Units to U.S. Wholesalers During the Fiscal Fourth Quarter of 2026

Source: PR Newswire • Published: 26 Oct 2026, 17:00

Summarized by Masters of Longevity from PR Newswire.

Wholesaler shipments of LYMPHIR rose 120% in fiscal Q4 2026.

Citius Oncology Reports Continued Institutional Demand and 120% Growth in Shipments of LYMPHIR® Units to U.S. Wholesalers During the Fiscal Fourth Quarter of 2026
Key Takeaways
  • Wholesaler LYMPHIR unit sales increased by 120% in Q4.
  • Prescribing centers ordered 950 LYMPHIR vials during the quarter.
  • Preliminary shipment figures are unaudited and may still change.
Read the full article at PR Newswire ↗

Continue exploring

Recommended MoL Picks

MoL PickGrowth Hormone Receptor Deletion Extends Mouse LifespanStudy summary: researchers switched off the growth hormone receptor in middle-aged mice and followed survival and physical function.MoL PickBiotin for Hair Growth: The Weak Evidence—and the Blood-Test Risk Most People MissBiotin deficiency can affect hair. That does not mean more biotin makes healthy hair grow—and high doses can distort important laboratory results.MoL PickApple Brings Longevity to the Wrist. What Will It Change?Apple’s new Health Age, readiness and movement tools bring long-term health into everyday view. The opportunity is turning that information into useful action.